IBCSG Long Term Follow-Up Medication Form (18-LTF-M) Source Form: NCI FormBuilder:

  1. 8/26/12 8/26/12 -
  2. 6/20/17 6/20/17 - Martin Dugas
Uploaded on:

June 20, 2017

To request one please log in.
License :
Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

IBCSG Long Term Follow-Up Medication Form (18-LTF-M)

Instructions: This form is to be completed if the patient received bone active medication, non-steroidal, anti-inflammatory drug or extended adjuvant therapy during this follow-up period. Use minus one (-1) to indicate that an answer is unknown, unobtainable or not done

Header Module
Long Term Follow-up Medication
Did the patient receive bone active medication other than calcium or vitamin D during this follow-up period (e.g., bisphosphonates)
If yes or continuing
Did the patient receive glucocorticosteroids during this follow-up period
Did the patient receive continuous, non-steroidal, anti-inflammatory drug during this follow-up period (e.g., COX-2 inhibitors, aspirin, Ibuprofen)
Did patient receive extended adjuvant endocrine therapy for primary breast cancer during this follow-up period (If treatment was given for breast cancer recurrence, do not record)
Adjuvant Hormonal Therapy Administered Type (Extended)
Reason Stopped (If extended treatment stopped, what was the reason)
Footer Module
day month year

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial